Application of Prins cyclisation to Stereoselective Total Synthesis of natural products: Aculeatin A and B, Xestodecalactone C and epi-Sporostatin, (10S, 12S)-10-Hydroxy-12-methyl-1-oxacyclododecane-2, 5-Dione by Neetipalli, Thrimurtulu
SYNOPSIS
      
The title of the thesis is “Application of Prins cyclisation to Stereoselective Total Synthesis of natural products: Aculeatin A and B, Xestodecalactone C and epi-Sporostatin, (10S, 12S)-10-Hydroxy-12-methyl-1-oxacyclododecane-2, 5-Dione.” The quantum of thesis work carried out is divided into three chapters.

CHAPTER I: This chapter is divided into two sections A and B.
Section A: This section describes introduction to Prins cyclisation, previous approaches to the key intermediate 1, 3 diols.
Section B: This section elaborates the introduction and Stereoselective total synthesis of Aculeatin A and B via Prins cyclisation.
	
CHAPTER II: This chapter is further divided into two sections A and B.	
SECTION A: This section describes introduction, known synthetic approaches of Xestodecalactone C and Sporostatin.
SECTION B:	This section describes Stereoselective total synthesis of Xestodecalactone C and epi-Sporostatin via the Prins cyclisation.

CHAPTER III: The chapter is also depicted in two sections A and B.
SECTION A: This section describes introduction, known synthetic approaches of 12-membered lactone.	
SECTION B: This section describes the Stereoselective total synthesis of (10S, 12S)-10-hydroxy-12-methyl-1-oxacyclododecane-2, 5-Dione via the Prins cyclisation.

CHAPTER I:
Section A: This section describes introduction to Prins cyclisation, previous approaches to the key intermediate 1, 3 diols.
Section B: This section elaborates the introduction and Stereoselective total synthesis of Aculeatin A and B via Prins cyclisation.
                                  The Aculeatins A-D (Figure 1, 1-4) represent a novel type of natural compounds displaying the unusual, previously unreported 1, 7-dioxadispiro [5.1.5.2] pentadecane system.  The Aculeatins A (1) and B (2) are two epimeric spiroacetals isolated from the terrestrial plant species Amomum aculeatim Roxb. (fam. Zingiberaceae).  A more complex variant, Aculeatin C (3), was also isolated from the same plant. Later, the same authors reported the isolation of fourth member of this compound family, named Aculeatin D and assigned structure and relative configuration 4. Aculeatin A (1) was found to be amongst the most cytotoxic of the compounds tested and was further evaluated in an in vivo hollow fiber assay. It was found to be active against MCF-7 (human breast cancer) cells implanted intraperitoneally at doses of 6.25, 12.5, 25, and 50 mg/kg. However, when Aculeatin A (1) was tested using P388 lymphocytic leukemia and human A2780 ovarian carcinoma in vivo models, it was deemed to be inactive at the doses used.
As Aculeatins have a novel framework and significant antiprotozoal, antibacterial and antitumoral activities, inspired by the cytotoxic effects and having fascinated spiroacetal frame work in the structure we investigated the synthesis of Aculeatin A and B via Prins cyclisation. Our group has made a significant effort to explore the utility of Prins cyclisation in the synthesis of various polyketide intermediates and applied it in the synthesis of some natural products. As a part of this ongoing programme, we have accomplished a stereoselective total synthesis of the Aculeatin A and B via Prins cyclisation.











Figure1
RETROSYNTHESIS:













Scheme1
The retrosynthetic analysis for the synthesis of Aculeatin A and B is outlined in scheme I.
                                Before the synthesis, a careful examination was made on retrosynthetic analysis (Scheme1). We have simplified the molecule into aliphatic fragment 5 and aromatic fragment 6. The aliphatic part is envisaged to be constructed from 7 which in turn could be drawn from pyranyl methanol 8. Pyranyl methanol 8 could be easily constructed via Prins cyclisation between homoallylicalcohol (HAA) 9 and tetradecanal following our recently developed methodology.
Synthesis of aliphatic fragment:








Scheme II
             The synthesis of aliphatic fragment is initiated from epichlorohydrin as described in Scheme II. Epichlorohydrin 10 on treatment with benzyl alcohol in tetrahydrofuran (THF) yielded benzyl glycidyl ether 11 using a well documented procedure. The Jacobsen HKR of compound 11 using (R, R)-(salen) cobalt (II) precatalyst, aceticacid (AcOH) and H2O (0.51 equiv) for 22 hours resulted in (S)-benzyl glycidyl ether 12 in 46% yield. Reaction of 12 with vinyl magnesium bromide in THF, in presence of CuCN resulted the coupled product 13 which on debenzylation gave homoallylic alcohol 9 in 75% yield. (Scheme II)  
                                                






Scheme III
               
                      Subjection of homoallylic alcohol 9 to crucial Prins cyclisation with tetradecanal  using trifluoroacetic acid (TFA) in CH​​2​Cl2 ​resulted in trisubstituted pyran 15 in 52% yield after hydrolysis of corresponding trifluoroacetate 14 using Potassium carbonate (K2CO3) in methanol.. The stereochemistry was assumed to be in accordance as it was well examined and established previously. However, it was proved after elaborating the compound 15 to the target molecule which in all respects was identical with the reported one. Tosylation with 1.1 equiv of tosyl chloride in the presence of TEA in DCM produced the corresponding primary tosylate 16 in 95% yield followed by secondary alcohol protection with TBSCl, DMAP and imidazole provided the corresponding TBS ether 17 in 92% yield. Exposure of compound 17 to sodium iodide (NaI) in refluxing acetone gave the corresponding iodo compound 18 in 95% yield. (Scheme III).   

 Scheme IV
                    Iodo compound 18 on exposure to unactivated Zn in refluxing ethanol furnished key open chain intermediate 19 with 96% yield. Alcohol 19 when subjected to standard Mitsunobu inversion conditions (DEAD, PPh3, p-nitro benzoic acid in THF then K2CO3, MeOH) yielded 20 in 86% yield followed by secondary alcohol protection with TBSCl, DMAP and imidazole provided the corresponding di TBS ether 21 in 99%yield. Ozonolytic cleavage of the olefinic bond of 21 followed by further oxidation of the resulting crude aldehyde with NaClO2 and NaH2PO4 furnished acid 22 in 90%yield, which was converted to the amide 5 by treatment with morpholine and diisopropyl carbodiimide (DIC). (SchemeIV).  

Synthesis of Aromatic fragment:

Scheme V
          Aromatic fragment was synthesized from 4-Hydroxy benzaldehyde 23 was protected as benzyl ether 24 using BnBr and K2CO3 in 95% yield.  Aldehyde was subsequently treated with CBr4 and TPP to afford the dibromo olefin 25 in 87% yield.  The dibromo olefin was converted into alkyne 6 under Grignard reaction condition by treating with EtMgBr at 0 oC in 92% yield. (Scheme V).  
Synthesis of Aculeatin A and B:

                          Scheme VI
It was thought that the synthesis had reached to the stage for homologation on the other terminal. Hence, treatment of 5 with lithiated 4-benzyloxyphenyl acetylene 6 furnished alkynone 26 in 85% yield, further Catalytic hydrogenolysis with 10% Pd-C/H2 in methanol gave 27 in 88% yield. The later on desilylated with TBAF which without purification treated with Phenyliodonium (III) bis (trifluoroacetate) in Acetone –Water (9:1) yielded a mixture of Aculeatins A and B in a ratio of 2.5:1, which were smoothly separated by column chromatography. Synthetic compound 1 and 2 has showed spectral and analytical data (1H NMR, 13C NMR, IR, Rf and D) identical to the previously synthesized sample.
                      
CHAPTER II: In this chapter the work is presented into two sections A and B.
	
SECTION A: This section describes introduction, known synthetic approaches of Xestodecalactone C and Sporostatin 
SECTION B: This section describes Stereoselective synthesis of Xestodecalactone C and epi-sporostatin via the Prins cyclisation.
                                Marine microorganisms have evolved as a source for novel bioactive compounds, more than 800 microorganisms have so far been isolated from marine sediments and organisms.  Xestadecalactones A, B, C (Figure 2)were isolated from the fungus penicillium cf. montanense which in turn was isolated from Xestospongia exigua.These new compounds were structurally related to a number of compounds isolated from terrestrial fungi. One of those, Sporostatin (1) and Curvularins (5).
                 Sporostatin (1) is an inhibitor isolated from a fungus of Sporormiella sp. M5032 as an inhibitor of cyclic adenosine 3’5’-monophosphate Phosphodietererase. All these compounds constitute a 10-membered macrolide derivative with a 1, 3-dihydroxybenzene ring. Xetodecalactones A-C (2, 3, 4) have been found to exhibit antibacterial and antifungal activities. Inhibitory activity of Sporostatin (1) against cAMP-PDE from bovine heart expressed in terms of 50% inhibition (IC50) was 41µg/ml, and it was noncompetitive against cAMP. It was found to be a specific inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase in vitro. In view of their biological activity, we were interested in the total synthesis of Xestadecalactone C and epi-Sporostatin via Prins cyclisation.
           










Figure 2
 Sporostatin (1), Xestadecalactone A (2), Xestadecalactone B, C (3, 4), Curvularins (5).
                  In our retrosynthetic analysis (SchemeVII) we envisaged that the target molecules 1, 4 could be achieved from a common intermediate 5 through AlI3 reaction. Compound 5 was viewed to be obtained from Mitsunobu product 6 using intramolecular Friedel-Crafts reaction. It was proposed to obtain the 1, 3 diol 7 from 2, 4, 6 substituted pyran 8 which in turn  would be obtained through Prins cyclisation of homoallylic alcohol 9 and Acetaldehyde.
          
SchemeVII
                                 The stereoselective total synthesis of Xestadecalactone (4) and epi-Sporostatin (1) started with chiral homoallyl alcohol (9).Cu mediated regioselective opening of S-(-)-benzyl glycidyl ether with vinylmagnesiumbromide followed by treatment with Li or Na in liquid ammonia debenzylation produced homoallylic alcohol 9.


Scheme VIII
               Prins cyclisation of homoallylic alcohol 9 with Acetaldehyde in the presence of                                                                                 TFA followed by hydrolysis of the resulting trifluoroacetate gave trisubstituted pyran 8 in 52% yield. Stereochemistry was assumed to be in anticipated line as it was well examined and established previously. However, it was proved after elaborating the compound 8 to the target molecule which in all respects was identical with the reported one. Tosylation with 1.1 equiv of tosyl chloride in the presence of TEA in DCM produced the corresponding primary tosylate 12 in 96% yield. TBS protection of the secondary alcohol in 12 with TBSCl, DMAP and imidazole provided the corresponding TBS ether 13 in 99% yield. Treatment of tosylate 13 with NaI in refluxing acetone gave the corresponding iodo compound 14 in 94% yield. (Scheme VIII).  

                          
Scheme IX
                           Iodo compound 14 on exposure to unactivated Zn in refluxing ethanol furnished key open chain intermediate 7 with the required anti-1, 3- diol system in 96% yield. Alcohol 7 when subjected to Mitsunobu reaction conditions DEAD, PPh3, 3,5,dimethoxyphenyl acetic acid in THF yielded 6 in 86% yield. Ozonolytic cleavage of the olefinic bond of 6 followed by further oxidation to acid with NaClO2 and NaH2PO4 gave the corresponding acid 16 in 90% yield. (Scheme IX).           



Scheme X
                  The macrolide 5 was obtained by intramolecular Friedel- Crafts reaction of the carboxylic acid 16 with a mixture of trifluoroacetic acid and trifluoroacetic acid anhydride in 41% yield (rt, 30min). Deprotection of the methoxy groups of 5 using freshly prepared AlI3 furnished the target molecules Xestodecalactone C (AlI3, 100C, 45min, 96%), epi-Sporostatin (AlI3, rt, 12h, 94%).
               
CHAPTER III: This chapter is also further divided into two sections A and B.
SECTION A: This section describes introduction, known synthetic approaches of 12-membered lactone.	
SECTION B: This section describes the Stereoselective total synthesis of (10S, 12S)-10-Hydroxy-12-methyl-1-oxacyclododecane-2, 5-Dione via the Prins cyclisation.
                                     The (10S, 12S)-10-hydroxy-12-methyl-1-oxacyclododecan-2, 5-dione, whose absolute stereochemistry of the two hydroxyl functionalities at C10 and C12 was originally assigned as depicted in 1 (Figure 3), was isolated from the endophytic fungal strain Cladosporium tenuissimum LR463 of Maytenus hookeri. It is found to induce rapid systematic defense responses in plants i.e. the production of peroxidase, phenylalanine ammonia lyase, lignin and salicylic acid. 

As a part of our interest on the synthesis of biologically active molecules, here in we report the synthesis of (10S, 12S)-10-hydroxy-12-methyl-1-oxacyclododecan-2, 5-dione (1).


Figure 3
               In our retrosynthetic analysis (Scheme XI), we envisaged that the target molecule could be achieved from 2 through Ring Closing Metathesis (RCM). Compound 2 could be obtained from 3 and 4 by esterification reaction. It is proposed to obtain the 1, 3-diol 3 from 2, 4, 6-substituted pyran 5 which in turn could be obtained via Prins cyclisation of homoallylic alcohol 9 and acetaldehyde. Compound 4 could be obtained from the Pent-4-en-1-ol 6.

Scheme XI
                              Accordingly, the total synthesis of 1 began with chiral homoallyl alcohol 9. Cupper (Cu) mediated regioselective opening of S-(-)-benzyl glycidyl ether (7) with vinylmagnesium bromide followed by debenzylation with sodium (Na) in liquid ammonia gave homoallyl alcohol 9. Prins cyclisation of compound 9 with acetaldehyde in the presence of TFA followed by hydrolysis of the resulting trifluoroacetate gave trisubstituted pyran 5 in 52% yield. The stereochemistry of compound 5 was assumed to be in anticipated line as it was well examined and established previously. Furthermore, it was proved after elaborating the compound 5 to the target molecule which was identical in all respects with the reported one. Tosylation of compound 5 with 1.1 equiv of tosyl chloride in the presence of TEA in DCM afforded the corresponding primary tosylate 10 in 96% yield. TBS protection of the secondary alcohol 10 with TBSCl, DMAP and imidazole gave the corresponding TBS ether 11. Treatment of tosylate 11 with NaI in refluxing acetone gave the corresponding iodo compound 12.


Scheme XII
                   Exposure of compound 12 to unactivated zinc in refluxing ethanol gave the key intermediate 13 (anti-1, 3-diol) in 96% yield. Esterification of free OH group of 13 with 4-benzyloxy-hept-6-enoic acid 4 in the presence of DCC and a catalytic amount of DMAP gave the diene 9 in 85% yield and set a stage for macrocyclization by ring closing metathesis.

Scheme XIII
                  The compound 4 was synthesized starting from pent-4-en-1-ol 4. Accordingly, compound 6 was protected as its tetrahydropyranyl ether 16, which upon epoxidation with m-CPBA resulted in the terminal epoxide 17 in 85% yield. Regioselective opening of the epoxide 17 with vinylmagnesium bromide gave the secondary alcohol 18 in 92% yield. Protection of the free hydroxy group as its benzyl ether 19 in 94% yield using BnBr in the presence of Sodiumhydride (NaH) and a catalytic amount of TBAI followed by deprotection of the THP ether with PTSA in MeOH gave the primary alcohol 20. Oxidation of the primary alcohol with DMP in DCM followed by further oxidation of the resulting crude aldehyde with NaClO2 and NaH2PO4 furnished benzyloxy acid 4 (90%), which was the key component used in the bis-olefin formation.

Scheme XIV

              The compound 2 possessed all the structural requirements as well as the sense of chirality to be converted into target macrolide via the Ring Closing Metathesis (RCM) reaction. The RCM reaction provides a remarkable scope for the synthesis of medium sized rings and macrocyclic products and is being used extensively. The presence of a suitable functionality and its distance from the olefins play key roles in the success of the metathesis reaction. It has been reported that the RCM reaction proceeds satisfactorily with substrates possessing a 6-heptenoate moiety, which is present in the dienic derivative 2. 
Scheme XV
                  Thus treatment of the diene 2 with 5 mol% Grubb’s II catalyst under high dilution conditions (0.001 M in DCM) gave compound 13 exclusively in 65% yield. Ttreatment of the cyclic ester 13 with Pd/C in MeOH afforded 14 (85%) wherein the two reactions, benzyl deprotection along with the reduction of the double bond were accomplished by a single reaction. 


Scheme XVI
          The resulting secondary hydroxyl was oxidized using Dess-Martin periodinane in CH2Cl2 to gave the ketone 15 (92%). Subsequent deprotection of TBS ether by TBAF in THF afforded macrolactone 1 (83%) as a white solid, m. p: 70-72 oC; [α]D25 +68.5 (c 1.0, MeOH) {lit.2 []25D +68.1 (c 0.25, MeOH )} which was identical in all respects to the reported value.














